Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated ..
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened ..
With six approved drugs, namely POLIVY™, LUMOXITI™, BESPONSA®, MYLOTARG™, KADCYLA®, ADCETRIS® and over 300 drugs underdevelopment, antibody drug ..
The steadily growing demand for vaccines, fueled by the COVID-19 pandemic, coupled to the discovery and development of a variety of preventive and therapeutic ..
The rapidly growing clinical pipeline and challenges associated with the conduct of clinical trials in a cost and time effective manner, has presented ..
London Roots Analysis has announced the addition of “Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030” report to its list of offerings. ..
Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order ..
The Collaborative Robots Market, 2020-2030” report features an extensive study of the potential applications, current landscape and the likely adoption ..
Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that are produced by the immune system in response to foreign molecules (antigens) ..
Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have developed container-closures systems using more versatile ..
The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-continuous ..
Besides portability, handheld X-ray scanners offer a wide range of benefits, including cost savings; in the initial days of the pandemic, such devices ..
Given the limitations of current clinical trial approaches, including inefficient patient management and data handling, trial sponsors are increasingly ..
The rapidly growing clinical pipeline and challenges associated with the conduct of clinical trials in a cost and time effective manner, has presented ..
In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition ..
London Roots Analysis has announced the addition of “Home Blood Collection Devices market, 2021-2030” report to its list of offerings. The inherent ..
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products ..
During our research, we were able to capture more than 40 players, which claims to offer bioassay services related for cell and gene therapies. ..
Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth ..
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative ..
Primary packaging material plays a crucial role in preserving the stability, efficacy and safety of the drug as it is in direct contact with the packaged ..
The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer ..
The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has presented lucrative ..
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed ..